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Abstract: Various natural compounds have been successfully tested for preventing or counteracting
the toxic effects of exposure to heavy metals. In this study, we analyzed the effects of cadmium
chloride (CdCl2) on immortalized, non-tumorigenic thyroid cells Nthy-ori-3-1. We investigated the
molecular mechanism underlying its toxic action as well as the potential protective effect of quercetin
against CdCl2-induced damage. CdCl2 suppressed cell growth in a dose- and time-dependent
manner (IC50 value ~10 µM) associated with a decrease in levels of phospho-ERK. In addition,
CdCl2 elicited an increase in reactive oxygen species (ROS) production and lipid peroxidation.
A significant increase in GRP78, an endoplasmic reticulum (ER) stress-related protein, was also
observed. Supplementation of quercetin counteracted the growth-inhibiting action of CdCl2 by
recovering ERK protein phosphorylation levels, attenuating ROS overproduction, decreasing MDA
content and reducing the expression of GRP78 in cells exposed to CdCl2. Thus, in addition to revealing
the molecular effects involved in cadmium-induced toxicity, the present study demonstrated, for the
first time, a protective effect of quercetin against cadmium-induced damages to normal thyroid cells.
Keywords: endocrine disruptors; normal thyroid cells; cadmium; quercetin; ROS
1. Introduction
Cadmium (Cd) is one of the most toxic environmental pollutants derived from natural
sources as well as human activities. Contaminated air, water, food and cigarette smoke
are the major sources of human Cd exposure [1]. Because of its extremely long biological
half-life and low excretion rate, Cd may accumulate inside the body, causing a broad
range of cytotoxic effects, especially to the kidneys, liver and muscles [2,3]. The presence of
cysteine-rich proteins containing thiol groups able to bind Cd makes even the thyroid gland
a potential site of Cd deposition, and it has been reported that Cd blood concentration
correlates positively with its accumulation in thyroid tissue [4,5]. In accordance, in a
study conducted by Uetani et al. [6] in people living in a Cd-polluted area of Japan, Cd
concentrations in the thyroid gland were three times higher compared to those residing in
non-polluted areas [6]. Although Cd thyrotoxicosis has been widely documented, most
works have focused on thyroid hormone function, yielding conflicting data [4,5]. Few
studies have investigated the action of Cd on human thyroid cells and the underlying
molecular and cellular mechanisms involved in thyroid toxicity, and most studies have
been performed in cancer cell lines [7–9].
Modulation of cellular redox status via indirect increase in reactive oxygen species
(ROS) levels (i.e., decreased concentration of intracellular antioxidants and reduced activity
of antioxidant enzymes) and mitochondrial damage represents one of the main mechanisms
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of Cd-induced cytotoxicity [4,10]. Various antioxidant compounds present especially
in edible vegetables have been successfully tested for preventing or counteracting the
toxic effects of exposure to heavy metals including Cd [4,10,11]. In this context, the
flavonoid quercetin is considered a very promising potential therapeutic agent for its
strong antioxidant activity exerted by scavenging free radicals and chelating transition
metal ions responsible for the generation of ROS [12]. Indeed, various reports described
the protective effect of quercetin against Cd-induced cytotoxicity by attenuating lipid
peroxidation and increasing intracellular antioxidant action [13–15].
In the present study, we analyzed the effects of cadmium chloride (CdCl2) on non-
tumorigenic human thyroid cells and the molecular mechanism associated with its toxic
action. Moreover, we investigated the effects of quercetin against CdCl2-induced damage
in thyroid cells. Since studies on Cd blood and thyroid concentrations in humans produced
complex and often conflicting results [4,5], the experimental design adopted in our study
included dose- and time-response experiments in order to define Cd concentration.
2. Results
2.1. Effects of CdCl2 Alone or in Combination with Quercetin on Thyroid Cell Proliferation
We first evaluated the effect of exposure of Nthy-ori-3-1 thyroid cells to various
concentrations of CdCl2 (0.1, 0.5, 1, 5, 10, 50 and 100 µM) for 24, 48 and 72 h. By MTT assay,
we observed a time- and concentration-dependent decrease in cell proliferation (Figure 1a).
After 24 h of treatment, a reduction in cell growth was evident at 10 µM (IC50, p < 0.001),
and a stronger toxic effect of CdCl2 was observed after 72 h of treatment (~70% reduced
number over control, p < 0.001). The exposure to higher concentrations of CdCl2 (50 µM
and 100 µM) caused full inhibition of cell viability. Similar results were obtained by cell
counting (Figure 1b). Since it has been reported that the flavone quercetin is able to prevent
several damages caused by heavy metals, we tried to reverse the cytotoxic effect of CdCl2
by using this natural compound, dissolved in DMSO (control) at the concentration of 5 µM.
The addition of quercetin in the cells treated with CdCl2 10 µM counteracted the growth-
inhibiting action of CdCl2 (~20% over CdCl2 alone, after 24 h of treatment, p < 0.001)
(Figure 1c). Similar effects were obtained even after 48 and 72 h of co-administration of
both compounds (data not shown).
2.2. Modulation of the ERK Pathway in Thyroid Cells by CdCl2 and Effect of Quercetin
To investigate the molecular mechanism involved in the toxic effects of CdCl2 in
thyroid cells and the interfering action of quercetin, we analyzed the effects of short
exposure to these compounds on one of the main signal transduction pathways involved in
thyroid cell proliferation. In Nthy-ori-3-1 cells, treatment with CdCl2 10 µM for 3 h resulted
in a reduction in ERK phosphorylation without modifying the total levels of this protein
(Figure 2). Supplementation of quercetin 5 µM resulted in the recovery of ERK protein
phosphorylation levels.
2.3. Analysis of the Production of ROS in Thyroid Cells Exposed to CdCl2 and Effect of Quercetin
Many reports indicate that the production of ROS is enhanced by exposure to various
heavy metals including Cd. Thus, we examined by flow cytometry the effect of CdCl2 on
ROS production in Nthy-ori-3-1 cells. After 2 h of exposure (Figure 3), the resulting ROS
levels had enhanced approximately 10-fold in cells treated with CdCl2 10 µM compared to
untreated cells (p < 0.001 vs. control). This effect was attenuated when the cultures were
pre-treated for 24 h with quercetin 5 µM, as revealed by a leftward shift of fluorescence
(p < 0.01 vs. CdCl2 10 µM) (Figure 3a,b).
2.4. Effect of CdCl2 on Lipid Peroxidation and Endoplasmic Reticulum (ER) Stress
Malonildialdehyde (MDA) is a biomarker of oxidative damage, and its levels are
considered as a lipid peroxidation index. Thus, to investigate the effect of CdCl2 on lipid
peroxidation, we measured MDA levels in cells treated for 24 h with CdCl2 0.1, 1 or 10 µM
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alone or in combination with quercetin 5 µM. As shown in Figure 4, MDA production
was increased significantly after incubation with CdCl2 1 and 10 µM compared with
untreated cells (p < 0.001). This effect was significantly attenuated when the cultures were
supplemented with quercetin (p < 0.01 vs. CdCl2 1 and 10 µM).
Figure 1. (a,b) Effects of treatment with CdCl2 on thyroid cell viability. Nthy-ori-3-1 cell viability was
measured by MTT and cell count assays after 24, 48 and 72 h of treatment with various concentrations
of CdCl2. (c) Effects of quercetin on viability of Nthy-ori-3-1 cells treated with CdCl2. Quercetin and
CdCl2 were administrated alone or in combination, and cell viability was analyzed by MTT assay
after 24 h of treatment. Results are expressed as percentage of cell viability reduction vs. untreated
cells (Ctrl) (panels a and b) or vehicle (panel c), representing the mean ± SD of three independent
experiments. Statistical analysis was performed by using the Tukey–Kramer multiple comparisons
test. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. Ctrl, ◦◦◦ p < 0.001 vs. CdCl2 10 µM.
Finally, we evaluated the expression of GRP78, an ER stress-related protein [16], by
Western blotting analysis (Figure 5). A significant increase in GRP78 protein expression
was detected in Nthy-ori-3-1 cells exposed to 0.1 or 1 µM of CdCl2 for 2 h compared with
untreated cells. Again, this action was reversed by pretreatment with quercetin 5 µM for
24 h (Figure 5). No differences were observed in cells exposed to Cd 10 µM, probably
because at this concentration Cd exerts its cytotoxic effect and ER fails to overturn the
stressful conditions [17].
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Figure 2. Effects of CdCl2 and quercetin on ERK phosphorylation. Nthy-ori-3-1 cells were treated for
3 h with CdCl2 10 µM or/and quercetin 5 µM as described in the Methods. Immunoblot analysis
of phosphorylated ERK (p-ERK) and total form of the enzyme (ERK) was performed by Western
blotting. GAPDH was used as loading control. An immunoblot representative of three experiments
is shown.
Figure 3. ROS determination in Nthy-ori-3-1 exposed to CdCl2 and quercetin. Cells were pretreated
for 24 h with or without quercetin (Q) 5 µM and then exposed for 2 h at the indicated concentrations of
CdCl2; after incubation with H2DCF-DA, the fluorescence of DCF was evaluated by flow cytometry.
In panel (a), cytofluorimetric plots of a representative experiment of three separate determinations are
shown. Panel (b) shows the ROS production expressed as fold of increase with respect to untreated
cells (Ctrl) considered arbitrarily as 1. H2O2 (150 µM) was used as the internal positive control.
The results represent the mean ± SD of three independent experiments. Statistical analysis was
performed using the Tukey–Kramer multiple comparisons test. * p < 0.05, *** p < 0.01 vs. Ctrl;
◦◦ p < 0.01 vs. CdCl2 10 µM.
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Figure 4. Lipid peroxidation in Nthy-ori-3-1 exposed to CdCl2 and quercetin 5 µM. Lipid peroxidation
was evaluated by MDA assay (see Materials and Methods) after incubation of cells with quercetin
and CdCl2 alone or in combination for 24 h. MDA levels were expressed as fold of increase with
respect to untreated cells considered arbitrarily as 1. The results are means ± SD of two independent
experiments. Statistical analysis was performed using the Tukey–Kramer multiple comparisons test.
*** p < 0.001 vs. Ctrl; ◦◦ p < 0.01 vs. CdCl2 1 µM and 10 µM.
Figure 5. (a) Effects of quercetin on ER stress marker GRP78. Western blot analysis was performed
on Nthyori-3-1 cells exposed to CdCl2 and quercetin (5 µM) alone or in combination for 2 h, as
described in the Methods. β-Actin was used as loading control. An immunoblot representative of
three experiments is shown. (b) Densitometric analysis of GRP78 normalized to β-Actin. Values
are expressed as means ± SD from three experiments. Statistical analysis was performed using the
Tukey–Kramer multiple comparisons test. ** p < 0.01, *** p < 0.001 vs. control, ## p < 0.01 vs. CdCl2
0.1 µM.
3. Discussion
Cd has been identified as an endocrine-disrupting chemical for the thyroid gland [18].
Indeed, it has been reported that Cd exposure determined imbalanced plasma of T3,
T4 and TSH levels in in vivo experimental models and in humans, although these data
are often contradictory depending on the experimental models and the used dosage [5].
Moreover, other signs markers of Cd thyrotoxicity are histological changes detected in
the gland appearing with desquamation of follicular cells and an increase in fibrous
tissue and monocyte infiltration in the stroma of the thyroid [4]. Several mechanisms
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have been proposed to explain Cd cytotoxicity [3], but they have never been evaluated
directly in non-tumor thyroid cells. In the present study we used Nthy-ori-3-1 cells,
widely used as preclinical model of non-tumorigenic human thyrocytes, to analyze the
molecular alterations caused by CdCl2 involved in its toxic activity, focusing our attention
on the alterations of cellular redox status regulation. Our findings demonstrate that
CdCl2 suppresses cell growth in a dose- and time-dependent manner and is associated
with a decrease in the levels of phospho-ERK, suggesting the involvement of the MAPK-
mediated pathway, a well-established transduction pathway of regulation of thyrocyte
proliferation [19], and indicated as a target of Cd toxic action even in other cell types [20,21].
In addition, in our experimental model, CdCl2 elicited an increase in ROS levels, lipid
peroxidation and ER stress, suggesting that the toxic effect of Cd in thyroid cells may be
determined by the production of free radicals which, by stimulating lipid peroxidation in
biomembranes, lead to cell damage, as also documented by the up-regulation of GRP78, a
regulator of ER stress.
More interestingly, our findings demonstrate, for the first time, that the toxic action of
Cd on thyroid cells may be counteracted by the addition of quercetin, a bioflavonoid widely
distributed in vegetables and fruits known to have an extended spectrum of beneficial
effects on human health [22]. There are many reports that have described the ability of
this compound to mitigate the oxidative stress effects of various toxic compounds through
acting mainly as a ROS scavenger [12–14,23,24]. Other experimental evidence has suggested
that the cellular effects of polyphenols could be mediated by their interactions with specific
proteins of intracellular signaling cascades, including the MAPK pathways [25]. Therefore,
it was not surprising to detect a protective effect of quercetin against Cd-induced oxidative
damage in thyroid cells. Indeed, we found that supplementation of quercetin counteracted
the growth-inhibiting action of Cd, recovering ERK protein phosphorylation levels and
attenuating ROS overproduction. The protection against oxidative stress damage was also
confirmed by the decrease in lipid peroxidation observed in the cells exposed to Cd, as
already shown in other cell models [13,22], as well as by the reduction in the expression of
the ER resident chaperone GRP78, involved in the ER stress response determined by ROS
generation [16,20,26,27].
Recently, while our study was in progress, Yang et al. [28] described a protective action
against Cd thyrotoxicity exerted by fucoxanthin, a powerful antioxidant nutraceutical, con-
firming the validity of using natural antioxidants as a promising approach to fight against
this heavy metal-induced toxicity. Further studies, including the investigation of chronic
exposure of thyroid cells to mixtures of pollutants, will allow us to better characterize the
effects of the protective capacity of nutraceuticals against this endocrine disruptor.
4. Materials and Methods
4.1. Chemicals
CdCl2, dimethyl sulfoxide (DMSO), 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-
DA), glacial acetic acid, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) and quercetin were purchased from Merck Serono (Rome, Italy). RPMI 1640 and
phenol red-free RPMI were purchased from Thermo Fisher Scientific Inc. (Waltham, MA,
USA). Antibodies anti-ERK and anti-phospho-ERK were obtained from Santa Cruz Biotech-
nology (DBA, Segrate, Milan, Italy); anti-β-actin and anti-GAPDH were obtained from
Merck Serono (Rome, Italy), and anti-GRP78 was purchased from BD (Milan, Italy).
4.2. Cell Culture and Cell Proliferation Assays
Nthy-ori-3-1 thyroid cells, purchased from the European Collection of Authenticated
Cell Culture (ECACC, Public Health England, Porton Down, Salisbury, SP4 0JG, UK),
are human non-tumorigenic thyroid cells that express the thyroglobulin gene, but not
thyroperoxidase, and express only very low levels of both the TSH receptor and NIS
gene [29]. The cells were cultured in RPMI 1640 and maintained at 37 ◦C in a humidified
5% CO2 [29]. In the experiment, cells were seeded in 12- or 96-well plates at a density
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of 50 × 103 and 6 × 103, respectively. After 24 h the growth medium was replaced by
fresh normal medium supplemented with various doses of CdCl2 ranging from 0.1 to
100 µM, quercetin 5 µM, or its vehicle (DMSO) alone at a non-toxic concentration (below
10% v/v) [30]. After 24, 48 and 72 h in CdCl2, quercetin alone or in combination with
CdCl2 10 µM, cell proliferation was assessed by cell count or MTT assay [31,32]. For
cell counting, after treatment with CdCl2, viable cells were counted in chamber slides
(Countess, automated cell counter, Thermo Fisher Scientific) after Trypan blue staining.
For the MTT assay, a microplate spectrophotometer (xMark, Biorad, Milan, Italy) at a
wavelength of 540 nm and a reference wavelength of 690 nm was used to quantify the
solubilized product. Results are expressed as percentages over untreated cells or DMSO
(control), considered equal to 100 for each time (24, 48 and 72 h).
4.3. Western Blot Analysis
Twenty micrograms of total proteins, extracted as previously described [31], was
run on a 9 or 12% SDS PAGE gel, transferred to PVDF membranes (VWR, Milan, Italy),
blocked with TTBS/milk (TBS, 1% Tween 20 and 5% non-fat dry milk) and incubated
overnight with anti-ERK antibody diluted 1:100 or anti-phospho-ERK antibody diluted
1:500, anti-GRP78 antibody diluted 1:2000, and anti-β-actin or anti-GAPDH antibody
diluted 1:5000. The membranes were incubated with horseradish peroxidase-conjugated
antibody (Transduction Laboratories, Lexington, KY, USA) in TTBS/milk. The Western blot
detection system ECL Plus (Perkin Elmer, Monza, Italy) was used to visualize the proteins.
4.4. ROS Assay
ROS were measured as described by Lepore et al. [33]. Nthy-ori-3-1 cells were pre-
treated or not for 24 h with quercetin 5 µM and then exposed for 2 h to CdCl2 0.1, 1 and
10 µM. Subsequently, the cells were washed with PBS, trypsinized, resuspended in phenol
red-free RPMI medium containing a fluorescent probe H2DCF-DA (25 µM) and cultured
for 30 min at 37 ◦C. ROS production was evaluated by flow cytometric analysis using the
flow cytometer Accuri C6 (Becton Dickinson, San Jose, CA, USA). Hydrogen peroxide
(H2O2) 150 µM was used as an internal positive control.
4.5. MDA Assay
Lipid peroxidation was evaluated by measuring the reaction products of MDA with
thiobarbituric acid (TBA), which form a colorimetric product proportional to the MDA
present. The cells were placed in 10 cm diameter cell culture Petri dishes and, the following
day, were incubated for 24 h with medium containing CdCl2 0,1, 1 and 10 µM alone or
in combination with quercetin 5 µM. At the end of the treatment, cells were scraped, and
cell suspension was subjected to a freezing/thawing cycle. Subsequently, 36 mM TBA
dissolved in glacial acetic acid was added and the mixture heated for 60 min to 100 ◦C. The
reaction was interrupted by placing the vials on ice for 10 min, and a spectrophotometric
reading was carried out at 532 nm.
4.6. Statistical Analysis
The results are expressed as means ± standard deviation (SD). Statistical analysis was
conducted using GraphPad Prism version 5.0 statistical software (GraphPad Software Inc.,
San Diego, CA, USA). Comparisons among multiple groups were performed by one-way
ANOVA followed by the Tukey–Kramer test.
5. Conclusions
In summary, in this work we demonstrate that CdCl2 suppresses thyroid cell viability
in vitro by inhibiting the ERK1/2 pathway, inducing ROS generation and lipid peroxi-
dation and determining ER stress. We also found that addition of quercetin was able to
counteract Cd-toxic effects, encouraging the use of this nutraceutical for blocking the action
of this disruptor.
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